Cancer patients undergoing treatment are immunocompromised and at high risk for developing early complications leading to critical illness. Compared to complications encountered with conventional chemotherapy, new-generation immunotherapies pose unique diagnostic challenges because their presentation can be vague and nonspecific or can mimic autoimmune diseases.
Understanding the potential reactions that can occur from cannabis and synthetic cannabinoids can help emergency physicians recognize these effects in patients who may present to the emergency department.
A retrospective study found that among 1,488 hospitalized patients who received an antibiotic, 298 (20%) experienced at least one antibiotic-associated adverse drug event. Furthermore, 287 (19%) of the antibiotic regimens were not clinically indicated, and 56 (20%) of these were associated with an adverse drug event.
Prompt and honest communication with the patient and family members after an adverse event has become the best practice in healthcare over the past decade, and the federal government is supporting that effort with a new toolkit from the Agency for Healthcare Research and Quality.
Cardiovascular, pneumonia, and surgery patients exposed to fully electronic health records were less likely to experience in-hospital adverse events, according to a new study from the Agency for Healthcare Research and Quality.